Literature DB >> 10619809

Effects of continuous positive airway pressure on cardiac volumes in patients with ischemic and dilated cardiomyopathy.

S Mehta1, P P Liu, F S Fitzgerald, Y K Allidina, T Douglas Bradley.   

Abstract

The effects of continuous positive airway pressure (CPAP) on left (LV) and right ventricular (RV) volumes in patients with congestive heart failure (CHF) have not been studied. We hypothesized that CPAP would cause greater reductions in cardiac volumes in CHF patients with idiopathic dilated cardiomyopathy (IDC) than in those with ischemic cardiomyopathy (IsC), because their ventricles are more compliant. The effects of a 30-min CPAP application at 10 cm H(2)O on RV and LV end-diastolic (EDV) and end-systolic volumes (ESV), determined by radionuclide angiography, were therefore tested in 22 patients with CHF due to IsC (n = 13) or IDC (n = 9). CPAP-induced reductions in LVEDV, LVESV, RVEDV, and RVESV were significantly greater (p < 0.05) in the IDC than in the IsC group. Whereas in the IsC group CPAP caused no significant changes in LV or RV volumes, in the IDC group it induced significant reductions in RVEDV (527 +/- 77 ml to 354 +/- 50 ml, p = 0.03) and RVESV (400 +/- 78 ml to 272 +/- 54 ml, p = 0.04) that were greater than any reductions in LVEDV and LVESV. We conclude that CPAP causes greater short-term reductions in RV and LV volumes in CHF patients with IDC than in those with IsC, and that among patients with IDC, CPAP causes greater reductions in RV than in LV volumes.

Entities:  

Mesh:

Year:  2000        PMID: 10619809     DOI: 10.1164/ajrccm.161.1.9903055

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  13 in total

1.  Effects of obstructive sleep apnea treatment on left atrial volume and left atrial volume index.

Authors:  Akram Khan; Faisal Latif; Beau Hawkins; Maroun Tawk; Chittur A Sivaram; Gary Kinasewitz
Journal:  Sleep Breath       Date:  2008-05       Impact factor: 2.816

Review 2.  Interactions between respiration and systemic hemodynamics. Part II: practical implications in critical care.

Authors:  François Feihl; Alain F Broccard
Journal:  Intensive Care Med       Date:  2008-09-30       Impact factor: 17.440

Review 3.  Central sleep apnoea syndrome in patients with chronic heart disease: a critical review of the current literature.

Authors:  T Köhnlein; T Welte; L B Tan; M W Elliott
Journal:  Thorax       Date:  2002-06       Impact factor: 9.139

4.  [Cardiac effects of obstructive sleep apnea].

Authors:  S Steiner; R Willinghöfer
Journal:  Internist (Berl)       Date:  2010-07       Impact factor: 0.743

Review 5.  Canadian Thoracic Society 2011 guideline update: diagnosis and treatment of sleep disordered breathing.

Authors:  John Fleetham; Najib Ayas; Douglas Bradley; Michael Fitzpatrick; Thomas K Oliver; Debra Morrison; Frank Ryan; Frederick Series; Robert Skomro; Willis Tsai
Journal:  Can Respir J       Date:  2011 Jan-Feb       Impact factor: 2.409

Review 6.  [CPAP as adjunctive treatment option for chronic heart failure].

Authors:  C M Schannwell; B E Strauer
Journal:  Internist (Berl)       Date:  2006-02       Impact factor: 0.743

Review 7.  Central sleep apnea: implications for congestive heart failure.

Authors:  Arturo Garcia-Touchard; Virend K Somers; Lyle J Olson; Sean M Caples
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

Review 8.  [Cardiac effects of noninvasive ventilation].

Authors:  S Walterspacher; H Woehrle; M Dreher
Journal:  Herz       Date:  2014-02       Impact factor: 1.443

9.  Short-Term CPAP Improves Biventricular Function in Patients with Moderate-Severe OSA and Cardiometabolic Comorbidities.

Authors:  Ioana Mădălina Zota; Radu Andy Sascău; Cristian Stătescu; Grigore Tinică; Maria Magdalena Leon Constantin; Mihai Roca; Daniela Boișteanu; Larisa Anghel; Ovidiu Mitu; Florin Mitu
Journal:  Diagnostics (Basel)       Date:  2021-05-17

Review 10.  Sleep-disordered breathing in patients with heart failure: new trends in therapy.

Authors:  Anna Kazimierczak; Paweł Krzesiński; Krystian Krzyżanowski; Grzegorz Gielerak
Journal:  Biomed Res Int       Date:  2013-07-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.